131 results
S-1
EX-3.3
LRMR
Larimar Therapeutics Inc
18 Apr 14
IPO registration
12:00am
.
Section 2. Special Meetings.
Special meetings of the stockholders may be called by the President, Secretary or by a majority of the Directors … acting by vote or by written instrument(s) signed by such a majority of them.
Section 3. Place of Meetings.
All meetings of stockholders shall be held
424B5
xqoic0ne
27 Jun 18
Prospectus supplement for primary offering
4:49pm
S-1
EX-3.1
mu3wbqivf4cb5f 0k17d
18 Apr 14
IPO registration
12:00am
424B5
uqfpp
9 Nov 18
Prospectus supplement for primary offering
4:49pm
8-K
25ici95t
30 May 18
Zafgen, Inc. Expands Executive Leadership Team with Appointment of
5:17pm
424B5
hlwb2 8evdmu9dyssc1
14 Sep 22
Prospectus supplement for primary offering
7:28am
424B5
7juapoh19u7f
28 Jun 18
Prospectus supplement for primary offering
4:54pm
8-K/A
EX-99.1
7qbk3byh5a vyt
26 Jun 20
Other Events
5:08pm
8-K
EX-10.3
wtt2wjlbc0uokyh xn
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
hn2zlt4
12 Oct 17
Zafgen Appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to Continue as President, Appointed Chief Scientific Officer
12:00am